Bleeding Disorders Treatment Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • ID: 4520795
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Alnylam Pharmaceuticals
  • Baxalta
  • Bayer Pharmaceuticals
  • Biogen Idec
  • CSL Behring
  • Grifols
  • MORE
The report on global bleeding disorders treatment market provides qualitative and quantitative analysis for the period of 2015 to 2023. The report predicts the global bleeding disorders treatment market to grow with a CAGR of 8.5% over the forecast period of 2017-2023. The study on bleeding disorders treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2015 to 2023.

The report on bleeding disorders treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global bleeding disorders treatment market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global bleeding disorders treatment market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global bleeding disorders treatment market is segmented on the basis of type and drug class.

Global Bleeding Disorders Treatment Market by Type
  • Hemophilia A
  • Hemophilia B
  • Von Willebrand Disease
  • Others
Global Bleeding Disorders Treatment Market by Drug Class
  • Plasma-derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytics
  • Fibrin Sealants
  • Others
Company Profiles
  • Baxalta
  • Bayer Pharmaceuticals
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Biogen Idec
  • CSL Behring
  • Grifols
  • Octapharma
  • Alnylam Pharmaceuticals
  • Xenetic Biosciences, Inc.
How this report delivers?
1. Comprehensive analysis of global as well as regional markets of bleeding disorders treatment market.
2. Complete coverage of all the segments in bleeding disorders treatment market to analyze the trends, developments in the global market and forecast of market size up to 2023.
3. Comprehensive analysis of the companies operating in global bleeding disorders treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alnylam Pharmaceuticals
  • Baxalta
  • Bayer Pharmaceuticals
  • Biogen Idec
  • CSL Behring
  • Grifols
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary

3. Global Bleeding Disorders Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Bleeding Disorders Treatment Market

4. Global Bleeding Disorders Treatment Market by Type
4.1. Hemophilia A
4.2. Hemophilia B
4.3. Von Willebrand Disease
4.4. Others

5. Global Bleeding Disorders Treatment Market by Drug Class
5.1. Plasma-derived Coagulation Factor Concentrates
5.2. Recombinant Coagulation Factor Concentrates
5.3. Desmopressin
5.4. Antifibrinolytics
5.5. Fibrin Sealants
5.6. Others

6. Global Bleeding Disorders Treatment Market by Region 2017-2023
6.1. North America
6.1.1. North America Bleeding Disorders Treatment Market by Type
6.1.2. North America Bleeding Disorders Treatment Market by Drug Class
6.1.3. North America Bleeding Disorders Treatment Market by Country
6.2. Europe
6.2.1. Europe Bleeding Disorders Treatment Market by Type
6.2.2. Europe Bleeding Disorders Treatment Market by Drug Class
6.2.3. Europe Bleeding Disorders Treatment Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Bleeding Disorders Treatment Market by Type
6.3.2. Asia-Pacific Bleeding Disorders Treatment Market by Drug Class
6.3.3. Asia-Pacific Bleeding Disorders Treatment Market by Country
6.4. RoW
6.4.1. RoW Bleeding Disorders Treatment Market by Type
6.4.2. RoW Bleeding Disorders Treatment Market by Drug Class
6.4.3. RoW Bleeding Disorders Treatment Market by Sub-region

7. Company Covered
7.1. Baxalta
7.2. Bayer Pharmaceuticals
7.3. Novo Nordisk A/S
7.4. Pfizer Inc.
7.5. Biogen Idec
7.6. CSL Behring
7.7. Grifols
7.8. Octapharma
7.9. Alnylam Pharmaceuticals
7.10. Xenetic Biosciences, Inc.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Baxalta
  • Bayer Pharmaceuticals
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Biogen Idec
  • CSL Behring
  • Grifols
  • Octapharma
  • Alnylam Pharmaceuticals
  • Xenetic Biosciences, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll